Hepatitis B Prevention
Hepatitis B vaccine doses protect patients regardless of dialysis type
Published in Vaccine Weekly, August 10th, 2005
According to a study from Taiwan, "the doses of hepatitis B vaccine given to peritoneal dialysis (PD) patients are currently based on responsiveness data from hemodialysis (HD) patients. To determine whether the doses are also appropriate from PD patients, we did a head-to-head comparison of short-term and 2-year responses to hepatitis B vaccination of HD patients and PD patients."
"We evaluated serum titers of the antibody to hepatitis B surface antigen (anti-HBs) after the patients had completed a course of 4 consecutive intramuscular vaccinations (40 mcg of Engerix-B...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-08-10)
More Articles from Vaccine Weekly
- Breast Cancer Vaccine
A Tat fusion protein-based tumor vaccine for breast cancer developed - Chickenpox Vaccine
Oka/GSK attenuated varicella vaccine prevents chickenpox in clinical practice - HIV/AIDS Vaccine
Cross-reactivity of anti-HIV immune responses of major HIV-1 clades reported - Monoclonal Antibodies
Plant biopharming of monoclonal antibodies reviewed - Vector Development
Intracarotid delivery of oncolytic HSV vector to brain cancer reported - Animal Models
Nonhuman primates are models for hematology, immunology, and virology studies - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
